Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |